MedPath

Investigation of Genetic Disease Marker Associated With Korean Glaucoma Patients

Completed
Conditions
Single-nucleotide Polymorphism (SNP) for Glaucoma
Registration Number
NCT01025024
Lead Sponsor
Chungnam National University
Brief Summary

A single-nucleotide polymorphism (SNP) analysis of DNA obtained from peripheral blood of the glaucoma patients and the normal control will be performed to find genetic marker for primary open angle glaucoma.

Detailed Description

Unrelated Korean subjects who have primary open angle glaucoma were recruited in the current study. Genotyping for various SNP associated with POAG due to the linkage disequilibrium patterns is to be performed. Genotypes would be statistically compared between patients with primary open angle glaucoma and normal control subjects free of any eye diseases.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
1224
Inclusion Criteria
  • Clinical diagnosis of primary open angle glaucoma
Exclusion Criteria
  • Primary open angle glaucoma combined with congenital ocular disease
  • Primary open angel glaucoma combined with other ocular disease
  • Significant systemic disease other than systemic hypertension and diabetes

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
genotyping for the SNP associated with primary open angle glaucomaone year
Secondary Outcome Measures
NameTimeMethod
genotyping for rs7961953 and additional SNPs in TMTC2 from other linkage disequilibrium patternsone year

Trial Locations

Locations (1)

Chungnam National University Hospital

🇰🇷

Daejeon, Korea, Republic of

Chungnam National University Hospital
🇰🇷Daejeon, Korea, Republic of

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.